Healthleap raises $38M for its hospital alert AI

Healthleap claims to generate substantial financial returns for its hospital clients through automated sorting of records targeting often-missed pathologies. The startup, active in over 50 facilities and experiencing rapid growth, has secured $38 million to accelerate its development, expand its clinical scope, and prepare for an extension beyond the hospital setting.

Three-Year Contracts and Guaranteed ROI, with $23.8M Reported at Penn

Healthleap markets its platform through three-year contracts, with pricing depending on the number of licensed beds. The company also employs a results-based pricing model. It states that it relies on tangible return on investment validated by the hospitals' financial teams and contractually guarantees the delivery of multiples of the contract price. According to its leader, each client has observed a tangible ROI of at least five times, with some cases exceeding twenty times on an annual basis. At the University of Pennsylvania Hospital, the company reports an annualized financial impact of $23.8 million attributed to its malnutrition program, including $6.3 million in additional reimbursements and $17.5 million from shorter stays.

Over 50 Hospitals, Five Major Health Systems, and Revenue Increased Tenfold

The platform is deployed in more than 50 hospitals. Over the past year, Healthleap has grown from three partners to over 50, counting among its clients Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. During the same period, revenues are said to have increased by more than ten times, with no further details provided.

A Daily Risk Score Without a Diagnosis

Healthleap connects to electronic health records and uses linguistic models to extract information from clinical notes, which it combines with structured data such as lab reports and vital signs to highlight cases requiring special attention. The company clarifies that its software does not make diagnoses but merely points out areas for review. Every night, the records of all hospitalized adult patients are analyzed, including results, vital signs, weight, treatments, dietary orders, diagnoses, and notes; each morning, a risk score is integrated into the workflow along with a trends dashboard.

From Malnutrition to Delirium, Other Programs in Clinical Validation

The platform already identifies pathologies such as malnutrition and delirium. There are also programs for aspiration pneumonia, pressure ulcers, and the risk of readmission in cases of congestive heart failure, with these modules currently undergoing additional clinical validation. According to some publications, the proportion of hospitalized patients suffering from malnutrition ranges from 20% to 50%, and research links this condition to longer hospital stays, less effective healing, infections, other complications, as well as increased morbidity and mortality.

Origins of the Project, Funding Round, and Roadmap Beyond 40 Conditions

Founded in 2022 in South Africa by Jemima and Josiah Meyer, Healthleap started with a clinical nutrition tool designed for dietitians before pivoting to a platform aimed at identifying often-missed pathologies in hospitalized patients. Its developing approach aims to systematically extract relevant mentions from clinical notes, in addition to structured data such as lab results, weights, and vital signs. The company has raised $38 million, including $8 million in seed funding co-led by Sequoia Capital and First Round Capital, and $30 million in Series A led by Hummingbird Ventures; the valuation has not been disclosed. The funds are intended to finance development, product, sales, and customer success, with the goal of covering more than 40 major conditions and expanding into outpatient and home care.